One chromatin mechanism explains why a fifth of all cancers share a mutation
Loss of the BAF chromatin-remodelling complex, mutated in over 20% of human cancers, triggers abnormal 3D DNA folding that physically connects distant oncogenic enhancers to gene promoters. Blocking the CTCF partner protein restored normal architecture and suppressed tumours in preclinical models.